Srinivas Akkaraju's Net Worth
Srinivas Akkaraju's net worth is estimated to be at least $101,013,772.90 as of 09/18/2025. CoreStreet's estimation of Srinivas Akkaraju's net worth is based on their sale of stock and current holding of stock.
Srinivas Akkaraju is Director at Mineralys Therapeutics Inc. Common Stock. They have executed at least 23 trades of stock as per SEC Form 4 filings. Their most recent trade was for 588,235 units of MLYS stock on 09/04/2025. Their biggest sale was on 10/07/2024 when they sold 1,175,713 units of Scholar Rock Holding Corp stock for $34,389,605.25. They typically trade 2 times per year.
Total value of insider buys:
- $58,645,616.38
Total value of insider sells:
- $42,368,156.52
Most recent insider trade:
- Sept. 4, 2025
Srinivas Akkaraju's Insider Trading History
| Mineralys Therapeutics Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 4, 2025 | Director | 588,235 | $25.50 | Buy | $14,999,992.50 |
| Alumis Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 5, 2025 | Director | 160,370 | $4.67 | Buy | $748,927.90 |
May 2, 2025 | Director | 159,920 | $4.55 | Buy | $727,636.00 |
| Scholar Rock Holding Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 7, 2024 | Director | 1,175,713 | $29.25 | Sell | $34,389,605.25 |
| Syros Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 21, 2023 | Director | 904,977 | $4.42 | Buy | $3,999,998.34 |
June 25, 2020 | Director | 54,972 | $11.15 | Sell | $612,937.80 |
June 23, 2020 | Director | 50,953 | $11.11 | Sell | $566,087.83 |
April 9, 2019 | Director | 533,332 | $7.50 | Buy | $3,999,990.00 |
Jan. 31, 2018 | Director | 209,424 | $9.55 | Buy | $1,999,999.20 |
Dec. 14, 2017 | Director | 109,774 | $9.03 | Buy | $991,259.22 |
| Chinook Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 15, 2021 | Director | 1,215,000 | $14.00 | Buy | $17,010,000.00 |
Aug. 18, 2021 | Director | 208,500 | $11.98 | Buy | $2,497,830.00 |
| Intercept Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 12, 2021 | Director | 147,000 | $21.29 | Buy | $3,129,630.00 |
March 10, 2021 | Director | 90,000 | $20.96 | Buy | $1,886,400.00 |
Aug. 28, 2019 | Director | 5,207 | $60.32 | Buy | $314,086.24 |
Aug. 22, 2019 | Director | 67,784 | $66.37 | Buy | $4,498,824.08 |
Feb. 19, 2019 | Director | 23,438 | $128.78 | Sell | $3,018,345.64 |
Nov. 12, 2014 | Director | 2,000 | $167.19 | Buy | $334,380.00 |
Jan. 16, 2014 | Director | 3,250 | $267.94 | Sell | $870,805.00 |
| Aravive Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 2, 2019 | Director | 133,333 | $11.30 | Buy | $1,506,662.90 |
| Seagen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 21, 2019 | Director | 17,500 | $119.78 | Sell | $2,096,150.00 |
June 14, 2013 | Director | 5,000 | $32.75 | Sell | $163,750.00 |
May 10, 2013 | Director | 17,500 | $37.17 | Sell | $650,475.00 |